These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21973016)

  • 1. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
    Tokgoz H; Caliskan U; Lavigne-Lissalde G; Giansily-Blaizot M
    Haemophilia; 2012 Jan; 18(1):e25-7. PubMed ID: 21973016
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
    Mariani G; Napolitano M; Dolce A; Pérez Garrido R; Batorova A; Karimi M; Platokouki H; Auerswald G; Bertrand AM; Di Minno G; Schved JF; Bjerre J; Ingerslev J; Sørensen B; Ruiz-Saez A; ;
    Thromb Haemost; 2013 Feb; 109(2):238-47. PubMed ID: 23238632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
    İnce Z; Bulut Ö; Tuğrul-Aksakal M; Ünüvar A; Devecioğlu Ö; Çoban A
    Turk J Pediatr; 2018; 60(5):562-565. PubMed ID: 30968639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.
    Yilmaz AA; Yalcin S; Serdaroglu H; Sonmezer M; Uysalel A
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):693-5. PubMed ID: 18832912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new report of FVII-inhibitor in a patient suffering from severe congenital FVII deficiency.
    Borhany M; Delbes C; Giansily-Blaizot M; Zubair M; Ahmed MS; Fatima N; Shamsi T
    Haemophilia; 2015 Jul; 21(4):e336-8. PubMed ID: 25955166
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect.
    Morfini M; Batorova A; Mariani G; Auerswald G; Bernardi F; Di Minno G; Dolce A; Fede C; Giansily-Blaizot M; Ingerslev J; Martinowitz U; Napolitano M; Pinotti M; Schved JF;
    Thromb Haemost; 2014 Aug; 112(2):424-5. PubMed ID: 24763923
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
    Karimi M
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.
    Schulman S; Tjønnfjord GE; Wallensten R; Martinowitz U; Kenet G
    Thromb Haemost; 2005 Dec; 94(6):1177-80. PubMed ID: 16411390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.
    Faranoush M; Abolghasemi H; Toogeh G; Karimi M; Eshghi P; Managhchi M; Hoorfar H; Dehdezi BK; Mehrvar A; Khoeiny B; Kamyar K; Heshmat R; Baghaeipour MR; Mirbehbahani NB; Fayazfar R; Ahmadinejad M; Naderi M
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):724-8. PubMed ID: 24651301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prophylaxis with rFVIIa in hemophilia and inhibitors: recommendations from an experts committee from Argentina.
    Pérez Bianco R; Neme D; Candela M; Tezanos Pinto Md
    Medicina (B Aires); 2010; 70(3):209-14. PubMed ID: 20529768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients.
    Shams M; Dorgalaleh A; Safarian N; Emami AH; Zaker F; Tabibian S; Managhchi MR; Faranoush M; Tabatabaei T; Satari S; Rezvani MR
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):24-28. PubMed ID: 30585836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.
    Berrettini M; Mariani G; Schiavoni M; Rocino A; Di Paolantonio T; Longo G; Morfini M
    Haematologica; 2001 Jun; 86(6):640-5. PubMed ID: 11418374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of rFVIIa during surgery in a FVII-deficient patient: a case report from Japan.
    Nagao A; Hanabusa H; Takedani H
    Haemophilia; 2014 Jan; 20(1):e110-2. PubMed ID: 24354483
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney Transplant in a Patient With Factor VII Deficiency: Case Report.
    Abdeltawab K; Yagan J; Megahed M; Zahab MA; Gheith OA; Rida S; Nair P; Mahmoud T; Maher AM; Al-Mohareb S; Mohamed M; Al-Otaibi T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):142-144. PubMed ID: 30777540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
    Gorkom BL; Holme PA; Joch C; Rogosch T; Feussner A; McKeand W; Roberts J; van Heerde W
    Hematology; 2020 Dec; 25(1):17-25. PubMed ID: 31852380
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma.
    Liu N; Aldea S; François D; Cherqui-Michel M; Giansily-Blaizot M; Fischler M
    Br J Anaesth; 2009 Dec; 103(6):858-60. PubMed ID: 19846405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
    Tcheng WY; Donkin J; Konzal S; Wong WY
    Haemophilia; 2004 May; 10(3):295-8. PubMed ID: 15086331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.